A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 774 participants.

Also called NCT01648582

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 774 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01648582
Other papers using this trial's data
  • Effects of GLP-1 Receptor Agonists on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus: A 52-Week Clinical Study BioMed research international, 2021 DOI, PubMed 34580638, PMC8464416 In the PMC Open Access subset under CC BY.
  • The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus BioMed research international, 2019 DOI, PubMed 31950036, PMC6943972 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China, Mexico, Russia, South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01648582. Randomized; no masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2014-08 (actual). Results posted on 2015-07-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
Acronym
AWARD-CHN2
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Dulaglutide
Intervention (Drug)
Insulin glargine
Intervention (Drug)
Metformin
Intervention (Drug)
Sulfonylureas
Lead sponsor
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct01648582
Content hash
4301bf8d3078f09e78ae0d3082635bd4f1c5cb2c0e789c3a3618ffec6a716cda